Pharmacokinetics of amcenestrant in female hepatic impaired participants as compared to participants with normal hepatic function

Trial Identifier: POP16301
Sponsor: Sanofi
Start Date: November 2021
Primary Completion Date: May 2022
Study Completion Date: May 2022
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Germany Kiel, Germany, 24105
South Korea Cheongju-si, South Korea, 28644
South Korea, Seoul-teukbyeolsi Seoul, Seoul-teukbyeolsi, South Korea, 03080